List of works by Peter J Neumann

30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement

scientific article

A Call for Open-Source Cost-Effectiveness Analysis

scientific article published on 29 August 2017

A Call for Open-Source Cost-Effectiveness Analysis

scientific article published in April 2018

A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures

scientific article published on 06 December 2017

A Flexible Approach To Evidentiary Standards For Comparative Effectiveness Research ⬇️

scientific article published on October 1, 2010

A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]

scientific article published on 01 February 2018

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

scientific article published in February 2018

A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.

scientific article

A Review of Empirical Analyses of Disinvestment Initiatives

scientific article

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted

scientific article

A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006.

scientific article

A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline

scientific article

A framework for assessing the value of diagnostic imaging in the era of comparative effectiveness research

scientific article published in December 2011

A model of the economic impact of a bipolar disorder screening program in primary care

scientific article published on 11 August 2009

A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy

scientific article published on October 2011

A role for research: an observation on preventive services for women

scientific article

A strategic plan for integrating cost-effectiveness analysis into the US healthcare system.

scientific article published on April 2008

A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics

scientific article published in October 2013

A synthesis of cost-utility analysis literature in infectious disease

scientific article

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.

scientific article published on 23 March 2018

Adherence to the iDSI reference case among published cost-per-DALY averted studies

scientific article published on 01 May 2019

Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit

scientific article (publication date: September 2012)

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]

scientific article published on 01 February 2018

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

scientific article published on 17 May 2019

Analyzing the Cost Effectiveness of Policy Responses for COVID-19: The Importance of Capturing Social Consequences

scientific article published on 01 April 2020

Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?

scientific article published in January 2010

Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study

scientific article published on 01 December 2016

Bias in published cost effectiveness studies: systematic review

scientific article

Biotechnology and Medicare's new technology policy: lessons from three case studies

scientific article published on 01 September 2006

CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.

scientific article

Can We Better Prioritize Resources for Cost-Utility Research?

scientific article published in July 2005

Can we reliably benchmark health technology assessment organizations?

scientific article published on 01 April 2012

Cancer therapy costs influence treatment: a national survey of oncologists

scientific article published on 01 January 2010

Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports

scientific article published on 14 December 2018

Communicating and promoting comparative-effectiveness research findings

scientific article published in July 2013

Comparative Modeling to Inform Health Policy Decisions: A Step Forward

scientific article published on 05 November 2019

Comparative effectiveness research panel at the 2012 Advertising & Promotion Conference of the Food & Drug Law Institute

scientific article

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures

Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs

scientific article published on 9 August 2010

Correction to: Publication of Decision Model Source Code: Attitudes of Health Economics Authors

scientific article published on 01 November 2019

Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions

scientific article published on 01 June 2018

Cost effectiveness of topiramate in the prevention of migraines in the United States: an update

scientific article published on 01 December 2006

Cost savings and cost-effectiveness of clinical preventive care

scientific article published on 01 September 2009

Cost-Effectiveness Analysis 2.0.

scientific article published on 01 January 2017

Cost-Effectiveness Analysis Expands its Reach Worldwide

scientific article published in September 2016

Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far

scientific article published on 30 November 2019

Cost-Effectiveness Studies in the ICU: A Systematic Review

scientific article published on 01 August 2019

Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?

scientific article

Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives

scientific article published on 24 August 2018

Cost-effectiveness of PET in the diagnosis of Alzheimer disease.

scientific article

Cost-effectiveness of adherence-enhancing interventions: a systematic review.

scientific article

Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment

scientific article published in September 2005

Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence

scientific article published on 07 February 2015

Cost-utility analyses in orthopaedic surgery

scientific article

Cost-utility analyses of diagnostic laboratory tests: a systematic review

scientific article published on 06 August 2011

Cost-utility analysis studies of depression management: a systematic review

scientific article

Costing and perspective in published cost-effectiveness analysis

scientific article

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

scientific article published on 01 May 2020

Cross-national comparison of technology assessment processes

scientific article published in January 2004

Decision analytic models for Alzheimer's disease: state of the art and future directions.

scientific article published on May 2008

Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis

scientific article published on 20 April 2004

Dependence as a unifying construct in defining Alzheimer's disease severity

scientific article

Despite high costs, specialty drugs may offer value for money comparable to that of traditional drugs

scientific article published in October 2014

Development and validation of a grading system for the quality of cost-effectiveness studies

scientific article published in January 2003

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Medical Economic Perspective

scientific article published on 01 September 2007

Diffusion of published cost-utility analyses in the field of health policy and practice

scientific article published on January 2005

Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies

scientific article published on 01 December 2018

Do drug formulary policies reflect evidence of value?

scientific article

Does Medicare have an implicit cost-effectiveness threshold?

scientific article

Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?

scientific article

Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents

scientific article published on 01 August 2013

Does preventive care save money? Health economics and the presidential candidates

scientific article

Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments?

scientific article published on 07 October 2019

Drugs Cleared Through The FDA's Expedited Review Offer Greater Gains Than Drugs Approved By Conventional Process.

scientific article

EBM, HTA, and CER: clearing the confusion

scientific article

Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients.

scientific article published on 21 September 2017

Economic evaluation in the US: what is the missing link?

scientific article published on January 2006

Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States

scientific article published on 05 September 2012

Economic messages in prescription drug advertisements in medical journals

scientific article published in September 2002

Embracing the science of value in health

scientific article published on 01 July 2019

Emerging lessons from the drug effectiveness review project

scientific article (publication date: 2006)

Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval

scientific article published on 10 November 2016

FDA actions against health economic promotions, 2002-2011.

scientific article published on 15 June 2012

FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation

scientific article published in September 2002

Factors predicting Medicare national coverage: an empirical analysis.

scientific article published in March 2012

Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions

scientific article published on 01 April 2019

Future Directions for Cost-effectiveness Analyses in Health and Medicine

article

Growth and capacity for cost-effectiveness analysis in Africa

scientific article published on 15 May 2020

Growth and quality of the cost-utility literature, 1976-2001.

scientific article

Health Economics Tools and Precision Medicine: Opportunities and Challenges

scientific article published on 05 March 2020

Health utilities in Alzheimer's disease and implications for cost-effectiveness analysis

scientific article published in January 2005

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia

article

Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease

scientific article published on 5 September 2017

How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments

scientific article

How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

scientific article published on 01 January 2004

ICER's Revised Value Assessment Framework for 2017-2019: A Critique

scientific article published on 01 October 2017

Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures

scientific article published on 10 May 2013

Impact of referral patterns on the use of chemotherapy for lung cancer.

scientific article published in April 2002

Imputing productivity gains from clinical trials

scientific article published in July 2012

In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival

scientific article published on April 2012

Insurance coverage for genomic tests.

scientific article

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework

scientific article published on 13 June 2016

Is the United States ready for QALYs?

scientific article published on September 2009

Key principles for the improved conduct of health technology assessments for resource allocation decisions

scientific article published on 01 January 2008

Lack of Cost-Effectiveness Analyses to Address Healthy People 2020 Priority Areas.

scientific article published on 15 September 2016

Legislating against Use of Cost-Effectiveness Information ⬇️

scientific article published on October 14, 2010

Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers

scientific article published on 11 March 2010

Listening to Provenge--what a costly cancer treatment says about future Medicare policy

scientific article

Little Consistency In Evidence Cited By Commercial Plans For Specialty Drug Coverage

scientific article published on 01 November 2019

Long-term persistence in use of statin therapy in elderly patients

scientific article published on 01 July 2002

Low-value services in value-based insurance design.

scientific article

Mapping US commercial payers' coverage policies for medical interventions

scientific article published on September 2016

Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS.

scientific article published on November 2012

Measuring the Value of Prescription Drugs

scientific article published on 18 November 2015

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

scientific article published on 13 June 2016

Medicare Is Scrutinizing Evidence More Tightly For National Coverage Determinations

article

Medicare and cost-effectiveness analysis

scientific article

Medicare covers the majority of FDA-approved devices and Part B drugs, but restrictions and discrepancies remain

scientific article published on June 2013

Medicare's Interventions Coverage: The Authors Reply

scientific article published on 01 June 2015

Medicare's enduring struggle to define "reasonable and necessary" care

scientific article published on 31 October 2012

Medicare's national coverage decisions for technologies, 1999-2007.

scientific article

Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits

scientific article published on 29 June 2012

Medicare's use of cost-effectiveness analysis for prevention (but not for treatment).

scientific article

Migraine frequency and health utilities: findings from a multisite survey.

scientific article published in March 2008

Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care

scientific article

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs

scientific article published on 13 April 2020

Outcome measures for oncology alternative payment models: practical considerations and recommendations

scientific article published on 01 December 2019

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value

scientific article published on 7 February 2018

Patient Variability Seldom Assessed in Cost-Effectiveness Studies.

scientific article published in January 2018

Patient adherence: a blind spot in cost-effectiveness analyses?

scientific article

Patients' willingness to pay for autologous blood donation

Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk

scientific article published on June 2016

Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018

scientific article published on 22 July 2020

Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders

scientific article published on 01 January 2013

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys

scientific article published on 28 January 2020

Price and value in cancer care

scientific article published on 06 August 2015

Principles for planning and conducting comparative effectiveness research.

scientific article published on September 2012

Private payers disagree with Medicare over medical device coverage about half the time

scientific article published on August 2015

Private sector risk-sharing agreements in the United States: trends, barriers, and prospects

scientific article

Publication of Decision Model Source Code: Attitudes of Health Economics Authors

scientific article published on 01 November 2019

QALYs in 2018-Advantages and Concerns

scientific article published on 01 June 2018

Quality of abstracts of papers reporting original cost-effectiveness analyses

scientific article

Quality of clinical and economic evidence in dossier formulary submissions

scientific article published in July 2007

Racial and Ethnic Differences in Knowledge About One's Dementia Status

scientific article published on 13 April 2020

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

scientific article published on September 2016

Recommendations on Perspectives for the Reference Case

Reducing cardiovascular disease: opportunities and consequences

scientific article published on August 2008

Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy

scientific article published on 01 November 2019

Regression analysis on the variation in efficiency frontiers for prevention stage of HIV/AIDS.

scientific article

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus

scientific article published on May 2010

Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].

scientific article published in February 2018

Risk-Targeted Lung Cancer Screening

scientific article published in August 2018

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis

scientific article published on 2 January 2018

Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement

scientific article published on December 2011

Specialty Drug Coverage Varies Across Commercial Health Plans In The US

scientific article published on 01 July 2018

Taking stock of cost-effectiveness analysis of healthcare in China.

scientific article published on 14 May 2019

Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency

scientific article published on 01 January 2019

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients

scientific article published on 04 August 2016

The Potential Value of β-Amyloid Imaging for the Diagnosis and Management of Dementia: A Survey of Clinicians

scientific article published on 4 November 2016

The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study

scientific article

The Role of Decision Models in Health Care Policy: A Case Study.

scientific article

The State of Cost-Utility Analyses in Asia: A Systematic Review

scientific article published on 24 March 2015

The adoption of cost-effectiveness acceptability curves in cost-utility analyses

scientific article

The changing face of the cost-utility literature, 1990-2012.

scientific article published on 22 January 2015

The cost-effectiveness of biopharmaceuticals: a look at the evidence

scientific article

The economic burden of intracerebral hemorrhage: evidence from managed care.

scientific article published in June 2006

The economics of mild cognitive impairment

scientific article published on 8 November 2012

The impact of formulary drug exclusion policies on patients and healthcare costs

scientific article

The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.

scientific article published on 03 December 2016

The influence of time horizon on results of cost-effectiveness analyses

scientific article published on 14 May 2017

The lag from FDA approval to published cost-utility evidence

scientific article published on 12 January 2015

The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology

scientific article

The validity of dependence as a health outcome measure in Alzheimer's disease

scientific article published on 19 March 2013

The value of specialty pharmaceuticals - a systematic review

scientific article published on June 2014

Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries

scientific article published on April 2012

Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value Frameworks

scientific article published on February 2017

Trends in cost effectiveness analyses in orthopaedic surgery

scientific article

Trends in the measurement of health utilities in published cost-utility analyses

scientific article

Twenty years of cost-effectiveness analysis in medical imaging: are we improving?

scientific article

US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research

scientific article

US healthcare reform: implications for health economics and outcomes research

scientific article published on 01 June 2010

Understanding and improving value frameworks with real-world patient outcomes

scientific article published on 01 November 2018

Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models

scientific article published on 11 April 2017

Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease

scientific article published in April 2014

Updated Recommendations for Cost-effectiveness Studies-Reply.

scientific article

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold

scientific article

Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies

scientific article published on 21 February 2018

Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making

scientific article

Using Cost-Effectiveness Analysis in Health and Medicine

article

Using Decision Analysis To Better Evaluate Pediatric Clinical Guidelines

scientific article published on 01 September 2008

Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?

scientific article published on 28 April 2020

Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

scientific article

Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses.

scientific article

Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.

scientific article published on January 2007

Variation in US private health plans' coverage of orphan drugs

scientific article published on 01 October 2019

What can we learn from the U.S. expanded end-stage renal disease bundle?

scientific article published on 16 February 2013

What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits)

scientific article

When Does FDAMA Section 114 Apply? Ten Case Studies

scientific article

When Is Evidence Sufficient?

article

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs.

scientific article published on 2 October 2017

When does quality-adjusting life-years matter in cost-effectiveness analysis?

scientific article published on May 2004

When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology ⬇️

scientific article

When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature

scientific article

Where are we on "risk-sharing" agreements?

scientific article published on 14 June 2013

Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions

scientific article published on 11 July 2013

Why don't Americans use cost-effectiveness analysis?

scientific article

Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study

scientific article published in November 2004

Willingness to pay for diagnostic technologies: a review of the contingent valuation literature

scientific article published on 14 June 2013

Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents

scientific article published on 28 December 2010

Paulina is supported by:

About Paulina

Help